Basic Sciences Archives
Jun. 15, 2017—High circulating glucose, the hallmark of diabetes, is linked to the disease’s most serious complications including heart disease, kidney failure, blindness and amputation. Diabetes is the sixth leading cause of death and costs the nation an estimated $322 billion a year. Restoring the action of insulin has been the traditional treatment route. Insulin, a hormone...
Apr. 13, 2017—Vanderbilt University School of Medicine (VUSM) now ranks No. 8 in the nation among U.S. medical schools in total grant support provided through the National Institutes of Health (NIH). The new ranking raises VUSM’s standing two spots from the No. 10 position it held last year.
Apr. 3, 2017—UCLA's Dr. Stephanie Correa is the next speaker in the Discovery Science Emerging Scholars Lecture series. She will discuss "Sex-Specific Neural Regulation of Energy Balance" beginning at 4 p.m. April 13 in Preston Research Building, Room 206.
Mar. 10, 2017—Rene Raphemot, who earned his Ph.D. at Vanderbilt in 2014 and is now a National Institutes of Health Postdoctoral Fellow at Duke University, will give the inaugural Discovery Science Emerging Scholars Lecture beginning at 4 p.m. Thursday, March 16, in Preston Research Building, Room 206.
Feb. 13, 2017—Six new courses, ranging from the impact of African music on politics to the interdisciplinary applications of virtual reality to big data methods for smart city development, are among the second set of University Courses to be offered at Vanderbilt University.
Feb. 2, 2017—Researchers at Vanderbilt have identified what may be a genetic “smoking gun” for autism spectrum disorder (ASD) — a mutation in the gene for the critical neuronal protein CaMKII.
Jan. 24, 2017—Vivien Casagrande, Ph.D., a neuroscientist and professor at Vanderbilt University School of Medicine (VUSM) noted for her many contributions to the visual sciences, died peacefully at her home on Saturday, Jan. 21. She was 74.
Jan. 12, 2017—Craig Lindsley, Ph.D., a leader of Vanderbilt University School of Medicine’s groundbreaking drug discovery program, is the 2017 recipient of the Pharmacia-ASPET Award in Experimental Therapeutics from the American Society for Pharmacology and Experimental Therapeutics (ASPET).
Dec. 27, 2016—Vanderbilt University scientists have received notification from the U.S. Food and Drug Administration that testing in humans may proceed for an investigational new drug for Alzheimer's disease after more than 10 years of research by scientists at Vanderbilt University and Vanderbilt University Medical Center.